Search research articles
Contact Us
Filters
Showing results (91-100 of 179) with videos related to
Page
of 18
Sort By:
Cancer Research
|
March 5, 2004
Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding
Sydney M Evans, Kevin D Judy, Isolde Dunphy, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 14, 2009
Target-driven exploratory study of imatinib mesylate in children with solid malignancies by the Innovative Therapies for Children with Cancer (ITCC) European Consortium
Birgit Geoerger, Bruce Morland, Anna Ndiaye, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 29, 2012
Phase II study of vinorelbine and continuous low doses cyclophosphamide in children and young adults with a relapsed or refractory malignant solid tumour: good tolerance profile and efficacy in rhabdomyosarcoma--a report from the Société Française des Cancers et leucémies de l'Enfant et de l'adolescent (SFCE)
Véronique Minard-Colin, Jean-Laurent Ichante, Laurent Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 22, 2023
Regorafenib plus Vincristine and Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors: An Innovative Therapy for Children with Cancer Study
Michela Casanova, Francisco Bautista, Quentin Campbell-Hewson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 8, 2019
Efficacy and Safety of Dabrafenib in Pediatric Patients with <i>BRAF</i> V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study
Darren R Hargrave, Eric Bouffet, Uri Tabori, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 20, 2021
First-in-child phase I/II study of the dual mTORC1/2 inhibitor vistusertib (AZD2014) as monotherapy and in combination with topotecan-temozolomide in children with advanced malignancies: arms E and F of the AcSé-ESMART trial
Raphael J Morscher, Caroline Brard, Pablo Berlanga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 14, 2024
Evolution of the Innovative Therapies for Children With Cancer Consortium Trial Portfolio for Drug Development for Children With Cancer
Francisco Bautista, Jaime Verdú-Amorós, Birgit Geoerger, et al.
NPJ Precision Oncology
|
September 20, 2023
Sequential genomic analysis using a multisample/multiplatform approach to better define rhabdomyosarcoma progression and relapse
Henry de Traux de Wardin, Josephine K Dermawan, Marie-Sophie Merlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 4, 2021
Phase I or II Study of Ribociclib in Combination With Topotecan-Temozolomide or Everolimus in Children With Advanced Malignancies: Arms A and B of the AcSé-ESMART Trial
Francisco Bautista, Xavier Paoletti, Jonathan Rubino, et al.
Cancer
|
June 14, 2017
Assessment of programmed death-ligand 1 expression and tumor-associated immune cells in pediatric cancer tissues
Robbie G Majzner, Jason S Simon, Joseph F Grosso, et al.
Page
of 18
Search research articles
Search
Showing results (91-100 of 179) with videos related to
Sort By:
Page
of 18
Cancer Research
|
March 5, 2004
Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding
Sydney M Evans, Kevin D Judy, Isolde Dunphy, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 14, 2009
Target-driven exploratory study of imatinib mesylate in children with solid malignancies by the Innovative Therapies for Children with Cancer (ITCC) European Consortium
Birgit Geoerger, Bruce Morland, Anna Ndiaye, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 29, 2012
Phase II study of vinorelbine and continuous low doses cyclophosphamide in children and young adults with a relapsed or refractory malignant solid tumour: good tolerance profile and efficacy in rhabdomyosarcoma--a report from the Société Française des Cancers et leucémies de l'Enfant et de l'adolescent (SFCE)
Véronique Minard-Colin, Jean-Laurent Ichante, Laurent Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 22, 2023
Regorafenib plus Vincristine and Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors: An Innovative Therapy for Children with Cancer Study
Michela Casanova, Francisco Bautista, Quentin Campbell-Hewson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 8, 2019
Efficacy and Safety of Dabrafenib in Pediatric Patients with <i>BRAF</i> V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study
Darren R Hargrave, Eric Bouffet, Uri Tabori, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 20, 2021
First-in-child phase I/II study of the dual mTORC1/2 inhibitor vistusertib (AZD2014) as monotherapy and in combination with topotecan-temozolomide in children with advanced malignancies: arms E and F of the AcSé-ESMART trial
Raphael J Morscher, Caroline Brard, Pablo Berlanga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 14, 2024
Evolution of the Innovative Therapies for Children With Cancer Consortium Trial Portfolio for Drug Development for Children With Cancer
Francisco Bautista, Jaime Verdú-Amorós, Birgit Geoerger, et al.
NPJ Precision Oncology
|
September 20, 2023
Sequential genomic analysis using a multisample/multiplatform approach to better define rhabdomyosarcoma progression and relapse
Henry de Traux de Wardin, Josephine K Dermawan, Marie-Sophie Merlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 4, 2021
Phase I or II Study of Ribociclib in Combination With Topotecan-Temozolomide or Everolimus in Children With Advanced Malignancies: Arms A and B of the AcSé-ESMART Trial
Francisco Bautista, Xavier Paoletti, Jonathan Rubino, et al.
Cancer
|
June 14, 2017
Assessment of programmed death-ligand 1 expression and tumor-associated immune cells in pediatric cancer tissues
Robbie G Majzner, Jason S Simon, Joseph F Grosso, et al.
Page
of 18